03 Aug Jupiter Life Sciences Consulting Welcomes Catherine Beecher as Partner
LONDON – 3rd August 2021 Jupiter Life Sciences Consulting, a global leader in pricing and market access strategy in the biopharmaceutical industry, are delighted to announce the appointment of Catherine Beecher (Cathy) as Partner. Cathy will strengthen and help build the growing European team and provide her expertise to serve all our global clients on pricing, value and access strategy issues.
Cathy has over 20 years of pricing and market access experience through a variety of consulting roles in the EU and US as well as time in industry at Bristol Myers Squibb as UK pricing and market access lead. She specialises in pricing and market access strategy, evidence gap analysis, value story and objection handler development, negotiation training and mock payer negotiations as well as environment and pipeline assessments. Cathy’s involvement in the pricing and market access challenges experienced by numerous products over the years, and her strong connections with European payer experts, enable her to provide truly valuable insights, analogues and solutions for her clients.
“Having Cathy join the Jupiter team is an important milestone as we expand our company globally,” said Steve Slovick, CEO and Managing Partner, Jupiter Life Sciences Consulting. “The addition of her expertise and proven ability to work through our clients’ complex challenges, helping them to realize the full value of their innovations, underscores our commitment to being the leader in product commercialization support.”
“Cathy has years of experience facilitating a consulting work environment that encourages and supports all of our innovative and creative staff, while grounding insights in what matters to our clients,” said Ted Sweeney, President and Managing Partner. “Cathy’s background in industry provides our clients with comprehensive, collaborative thinking with a colleague who has experienced many of the same challenges they have in bringing assets to market, coupled with the perspective of having worked on many dozens of consulting engagements across therapy areas.”
“I am thrilled to be joining a company with a senior team that I have worked with before and I know to be entrepreneurial, inspiring and experts in their field,” said Cathy. “I look forward to the exciting journey ahead as we grow in Europe, evolve as a company, and continue to provide true value to our clients”
About Jupiter Life Sciences Consulting
Jupiter is a global team of strategy experts with a shared passion for shaping value, navigating market access and optimizing price for pharma and biotech innovators. Jupiter’s leadership has contributed to the commercial success of 75 percent of the top performing drugs in the market. The firm operates with an employee-owned model that is unique in the industry.
Jupiter delivers proven market access, pricing and commercialization strategies, payer engagement solutions, and litigation support. Jupiter equips clients to realize optimal market access through a deep understanding of stakeholders’ sensitivities and deliverables that are actionable for specific needs.
To learn more about Jupiter Life Sciences Consulting, visit www.jupiterls.com